LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: "Nothing is ever going to change if we don't start advocating for our child.": Community-level disclosure and stigma management strategies among parents of internationally adopted children living with PHIV.

    Bingaman, Amanda / Hamilton, Alison / Houpt, Bethany / Olivero, Rosemary / Fair, Cynthia

    Frontiers in public health

    2023  Volume 11, Page(s) 1091335

    Abstract: Background: The number of internationally adopted children living with perinatally-acquired HIV (IACP) in the U.S. is increasing, yet little is known about their families' experiences navigating HIV disclosure within a community context. This paper ... ...

    Abstract Background: The number of internationally adopted children living with perinatally-acquired HIV (IACP) in the U.S. is increasing, yet little is known about their families' experiences navigating HIV disclosure within a community context. This paper examines the lived experiences of adoptive parents as they navigate HIV disclosure and manage stigma toward their adopted children within their broader communities.
    Methods: A purposive sample of parents of IACP was recruited at two pediatric infectious disease clinics and via closed Facebook groups. Parents completed two semi-structured interviews approximately one year apart. Interview questions included strategies parents used to reduce the impact of community level stigma that their child is likely to encounter as they mature. Interviews were analyzed using Sort and Sift, Think and Shift analytic approach. All parents (n = 24) identified as white and most (
    Results: Analyses revealed that parents serve as advocates for their child by both supporting more public HIV disclosure at times, but also applying indirect strategies such as working to improve outdated sex education material. Knowledge of HIV disclosure laws empowered parents to make informed decisions about who, if anyone, in the community needed to know their child's HIV status.
    Conclusion: Families with IACP would benefit from HIV disclosure support/training and community-based HIV stigma reduction interventions.
    MeSH term(s) Humans ; Child ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Disclosure ; Child, Adopted ; Qualitative Research ; HIV Infections ; Parents
    Language English
    Publishing date 2023-03-17
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2711781-9
    ISSN 2296-2565 ; 2296-2565
    ISSN (online) 2296-2565
    ISSN 2296-2565
    DOI 10.3389/fpubh.2023.1091335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Long-Acting Antiretroviral Drug Therapy in Adolescents: Current Status and Future Prospects.

    Freij, Bishara J / Aldrich, Aileen M / Ogrin, Sara L / Olivero, Rosemary M

    Journal of the Pediatric Infectious Diseases Society

    2022  Volume 12, Issue 1, Page(s) 43–48

    Abstract: Approximately 50% of human immunodeficiency virus (HIV)-infected adolescents fail to achieve complete viral suppression, largely due to nonadherence to their antiretroviral drug regimens. Numerous personal, financial, and societal barriers contribute to ... ...

    Abstract Approximately 50% of human immunodeficiency virus (HIV)-infected adolescents fail to achieve complete viral suppression, largely due to nonadherence to their antiretroviral drug regimens. Numerous personal, financial, and societal barriers contribute to nonadherence, which may lead to the development of HIV drug resistance. Long-acting antiretroviral drugs hold the promise of improved adherence because they remove the need for swallowing one or more pills daily. Cabotegravir (an integrase strand transfer inhibitor) and rilpivirine (a non-nucleoside reverse transcriptase inhibitor) can now be intramuscularly co-administered to HIV-infected adolescents every 4-8 weeks if they are virologically suppressed and without resistance mutations to cabotegravir or rilpivirine. Adverse effects are few and non-severe. Widespread use of this complete antiretroviral therapy may be limited by drug costs, need for sites and skilled personnel who can administer the injections, and ethical challenges. Other long-acting medications and new antiretroviral therapy delivery systems are under active investigation and show great promise.
    MeSH term(s) Humans ; Adolescent ; Anti-HIV Agents ; Pharmaceutical Preparations ; HIV Infections/drug therapy ; Rilpivirine/adverse effects ; Anti-Retroviral Agents/therapeutic use
    Chemical Substances Anti-HIV Agents ; Pharmaceutical Preparations ; Rilpivirine (FI96A8X663) ; Anti-Retroviral Agents
    Language English
    Publishing date 2022-12-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piac134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Parent perspectives on sexual and reproductive health with internationally adopted youth living with HIV.

    Crump, Johanna / Alger, Sarah / Bryant, Yaphet / Crowell, Claudia / Olivero, Rosemary / Fair, Cynthia

    AIDS care

    2022  Volume 35, Issue 3, Page(s) 447–452

    Abstract: Evidence suggests an increasing number of US families are adopting internationally born children with HIV (IACH). Little is known about the experiences of adoptive parents, particularly how they help children navigate adolescence. Many adopted children ... ...

    Abstract Evidence suggests an increasing number of US families are adopting internationally born children with HIV (IACH). Little is known about the experiences of adoptive parents, particularly how they help children navigate adolescence. Many adopted children may have additional needs as they mature into adolescence. Forty-four parents of 51 IACH were recruited from three pediatric infectious disease clinics and social media sites. The majority identified as white (
    MeSH term(s) Child ; Humans ; Adolescent ; Female ; Child, Preschool ; HIV Infections/psychology ; HIV ; Reproductive Health ; Qualitative Research ; Parents/psychology
    Language English
    Publishing date 2022-10-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1012651-x
    ISSN 1360-0451 ; 0954-0121
    ISSN (online) 1360-0451
    ISSN 0954-0121
    DOI 10.1080/09540121.2022.2136351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Notes from the Field: Increase in Pediatric Intracranial Infections During the COVID-19 Pandemic - Eight Pediatric Hospitals, United States, March 2020-March 2022.

    Khuon, Daliya / Ogrin, Sara / Engels, Julie / Aldrich, Aileen / Olivero, Rosemary M

    MMWR. Morbidity and mortality weekly report

    2022  Volume 71, Issue 31, Page(s) 1000–1001

    MeSH term(s) COVID-19/epidemiology ; Child ; Hospitals, Pediatric ; Humans ; Pandemics ; Retrospective Studies ; SARS-CoV-2 ; Telemedicine ; United States/epidemiology
    Language English
    Publishing date 2022-08-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 412775-4
    ISSN 1545-861X ; 0149-2195
    ISSN (online) 1545-861X
    ISSN 0149-2195
    DOI 10.15585/mmwr.mm7131a4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: An Extremely Premature Newborn with Cutaneous Lesions.

    Olivero, Rosemary M / Caulfield, Adam J / Fulton, Barbara K

    NeoReviews

    2019  Volume 20, Issue 12, Page(s) e757–e760

    MeSH term(s) Abruptio Placentae/surgery ; Antifungal Agents/therapeutic use ; Aspergillosis/diagnosis ; Aspergillosis/pathology ; Aspergillosis/therapy ; Aspergillus fumigatus ; Cesarean Section ; Debridement ; Dermatomycoses/diagnosis ; Dermatomycoses/pathology ; Dermatomycoses/therapy ; Female ; Humans ; Infant, Extremely Premature ; Infant, Newborn ; Pregnancy ; Pregnancy Complications, Cardiovascular/surgery ; Pregnancy Trimester, Second ; Uterine Hemorrhage/surgery ; Voriconazole/therapeutic use
    Chemical Substances Antifungal Agents ; Voriconazole (JFU09I87TR)
    Language English
    Publishing date 2019-12-02
    Publishing country United States
    Document type Case Reports ; Journal Article
    ISSN 1526-9906
    ISSN (online) 1526-9906
    DOI 10.1542/neo.20-12-e757
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Risk Factors for Acquisition of Extended-spectrum Beta-lactamase and AmpC Resistant Gram-negative Bacteria in Critically Ill Infants With Congenital Heart Disease.

    Borst, Andrea K / Khuon, Daliya / Ogrin, Sara L / Olivero, Anthony D / Olivero, Rosemary M

    The Pediatric infectious disease journal

    2021  Volume 40, Issue 8, Page(s) 738–740

    Abstract: In a cohort of 257 infants with congenital heart disease admitted to the pediatric intensive care unit, 22 infants had positive cultures for extended-spectrum beta-lactamase or AmpC Gram-negative bacteria. These infants had longer exposure to broad- ... ...

    Abstract In a cohort of 257 infants with congenital heart disease admitted to the pediatric intensive care unit, 22 infants had positive cultures for extended-spectrum beta-lactamase or AmpC Gram-negative bacteria. These infants had longer exposure to broad-spectrum antibiotics, greater support with invasive devices and longer intensive care and hospital lengths of stay.
    MeSH term(s) Bacterial Proteins ; Case-Control Studies ; Citrobacter/enzymology ; Cohort Studies ; Critical Illness ; Cross Infection/microbiology ; Enterobacter/enzymology ; Escherichia coli/enzymology ; Female ; Gram-Negative Bacterial Infections/complications ; Heart Defects, Congenital/complications ; Hospitals, Pediatric ; Humans ; Infant ; Intensive Care Units, Pediatric ; Klebsiella/enzymology ; Male ; Prevalence ; Retrospective Studies ; Risk Factors ; Serratia/enzymology ; beta-Lactam Resistance ; beta-Lactamases
    Chemical Substances Bacterial Proteins ; AmpC beta-lactamases (EC 3.5.2.6) ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2021-01-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000003129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Benchmarking of Outpatient Pediatric Antibiotic Prescribing: Results of a Multicenter Collaborative.

    El Feghaly, Rana E / Herigon, Joshua C / Kronman, Matthew P / Wattles, Bethany A / Poole, Nicole M / Smith, Michael J / Vaughan, Ana M / Olivero, Rosemary / Patel, Sameer J / Wirtz, Ann / Willis, Zachary / Lee, Brian R

    Journal of the Pediatric Infectious Diseases Society

    2023  Volume 12, Issue 6, Page(s) 364–371

    Abstract: Background: Most antibiotic use occurs in ambulatory settings. No benchmarks exist for pediatric institutions to assess their outpatient antibiotic use and compare prescribing rates to peers. We aimed to share pediatric outpatient antibiotic use reports ...

    Abstract Background: Most antibiotic use occurs in ambulatory settings. No benchmarks exist for pediatric institutions to assess their outpatient antibiotic use and compare prescribing rates to peers. We aimed to share pediatric outpatient antibiotic use reports and benchmarking metrics nationally.
    Methods: We invited institutions from the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient (SHARPS-OP) Collaborative to contribute quarterly aggregate reports on antibiotic use from January 2019 to June 2022. Outpatient settings included emergency departments (ED), urgent care centers (UCC), primary care clinics (PCC) and telehealth encounters. Benchmarking metrics included the percentage of: (1) all acute encounters resulting in antibiotic prescriptions; (2) acute respiratory infection (ARI) encounters resulting in antibiotic prescriptions; and among ARI encounters receiving antibiotics, (3) the percentage receiving amoxicillin ("Amoxicillin index"); and (4) the percentage receiving azithromycin ("Azithromycin index"). We collected rates of antibiotic prescriptions with durations ≤7 days and >10 days from institutions able to provide validated duration data.
    Results: Twenty-one institutions submitted aggregate reports. Percent ARI encounters receiving antibiotics were highest in the UCC (40.2%), and lowest in telehealth (19.1%). Amoxicillin index was highest for the ED (76.2%), and lowest for telehealth (55.8%), while the azithromycin index was similar for ED, UCC, and PCC (3.8%, 3.7%, and 5.0% respectively). Antibiotic duration of ≤7 days varied substantially (46.4% for ED, 27.8% UCC, 23.7% telehealth, and 16.4% PCC).
    Conclusions: We developed a benchmarking platform for key pediatric outpatient antibiotic use metrics drawing data from multiple pediatric institutions nationally. These data may serve as a baseline measurement for future improvement work.
    MeSH term(s) Humans ; Child ; Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; Benchmarking ; Outpatients ; Practice Patterns, Physicians' ; Amoxicillin/therapeutic use ; Respiratory Tract Infections/drug therapy ; Inappropriate Prescribing
    Chemical Substances Anti-Bacterial Agents ; Azithromycin (83905-01-5) ; Amoxicillin (804826J2HU)
    Language English
    Publishing date 2023-06-01
    Publishing country England
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piad039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative.

    Poole, Nicole M / Lee, Brian R / Kronman, Matthew P / Smith, Michael J / Patel, Sameer J / Olivero, Rosemary / Wattles, Bethany A / Herigon, Joshua / Wirtz, Ann / El Feghaly, Rana E

    American journal of infection control

    2023  Volume 52, Issue 5, Page(s) 614–617

    Abstract: We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in "pre-shortage" (Jan 2019-Sep 2022) and "shortage" (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing ... ...

    Abstract We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in "pre-shortage" (Jan 2019-Sep 2022) and "shortage" (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing increased across settings, the proportion of amoxicillin prescriptions decreased. Variation was seen within and between institutions.
    Language English
    Publishing date 2023-12-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 392362-9
    ISSN 1527-3296 ; 0196-6553
    ISSN (online) 1527-3296
    ISSN 0196-6553
    DOI 10.1016/j.ajic.2023.12.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital.

    Aldrich, Aileen M / Argo, Taylor / Koehler, Tracy J / Olivero, Rosemary

    The Pediatric infectious disease journal

    2018  Volume 38, Issue 1, Page(s) 32–36

    Abstract: Background: Clostridium difficile infection (CDI) is one of the most common nosocomial infections in the United States, with an increasing incidence in children. Approximately 20% of pediatric patients develop recurrent infections. It's imperative to ... ...

    Abstract Background: Clostridium difficile infection (CDI) is one of the most common nosocomial infections in the United States, with an increasing incidence in children. Approximately 20% of pediatric patients develop recurrent infections. It's imperative to further analyze the incidence of recurrent CDI in the pediatric population and determine the most effective treatments. The primary goal of this study is to characterize children with recurrent CDI at our institution, including both hospital-acquired CDI (HA-CDI) and community-acquired CDI (CA-CDI) cases, summarize the various treatments utilized, including fecal microbiota transplant (FMT) and compare their success rates.
    Methods: A retrospective cohort study of pediatric patients 1-21 years of age treated for CDI at a single institution from January 2010 to December 2014 was performed.
    Results: There were 175 subjects with 215 separate episodes of CDI. Oral metronidazole was the most common initial treatment (145/207, 70%) followed by oral vancomycin (30/207, 15%), with recurrence rates of 30% (42/145) and 37% (11/30), respectively. Twenty-nine percent (63/215) of all initial CDI cases had at least 1 documented recurrence. Using multivariate analysis, subjects with HA-CDI were 2.6 times less likely to recur than those with CA-CDI (odds ratio: 0.39; 95% confidence interval: 0.18-0.85; P = 0.018). The overall success rate for FMT at our institution was 10/12 (83%).
    Conclusions: Our data show that cases of HA-CDI were less likely to recur compared with CA-CDI. Although currently reserved for multiply-recurrent cases, FMT was highly successful in our small cohort. More studies on FMT should be conducted to further evaluate its usefulness in the treatment of recurrent CDI in children.
    MeSH term(s) Adolescent ; Anti-Bacterial Agents/therapeutic use ; Child ; Child, Preschool ; Clostridium Infections/therapy ; Clostridium difficile/drug effects ; Diarrhea/microbiology ; Fecal Microbiota Transplantation ; Female ; Hospitals, Pediatric ; Humans ; Infant ; Male ; Recurrence ; Retrospective Studies ; Treatment Outcome ; Young Adult
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2018-03-29
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000002053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants.

    Knee, Daniel / Knoop, Serena / Davis, Alan T / Rawson, Brenda / DiCarlo, Anna / Olivero, Rosemary

    Journal of perinatology : official journal of the California Perinatal Association

    2019  Volume 39, Issue 8, Page(s) 1089–1097

    Abstract: Objective: To assess mortality and morbidities in very low birthweight (VLBW) infants before and after changing to a restrictive blood transfusion guideline (RTG).: Study design: This is a large retrospective study comparing outcomes of a liberal ... ...

    Abstract Objective: To assess mortality and morbidities in very low birthweight (VLBW) infants before and after changing to a restrictive blood transfusion guideline (RTG).
    Study design: This is a large retrospective study comparing outcomes of a liberal transfusion guideline (LTG) and RTG in VLBW infants admitted to a large single neonatal intensive care unit. Blood and platelet transfusion details, mortality, and diagnoses of frequently diagnosed morbidities were collected for each infant.
    Results: Mortality was similar between RTG and LTG groups (6.8% vs. 6.3%, p = 0.755). Rates of periventricular leukomalacia (PVL), retinopathy of prematurity (ROP), sepsis and the diagnosis of necrotizing enterocolitis (NEC) within 48 h of a PRBC transfusion were significantly lower with RTG (p < 0.05). Chronic lung disease was similar between groups.
    Conclusion: RTG are safe compared to LTG, and are associated with lower rates of PVL, ROP, transfusion-associated cases of NEC and sepsis.
    MeSH term(s) Blood Transfusion/economics ; Blood Transfusion/statistics & numerical data ; Cost Savings ; Enterocolitis, Necrotizing/epidemiology ; Female ; Hematocrit ; Humans ; Infant, Extremely Premature/blood ; Infant, Newborn ; Infant, Premature, Diseases/epidemiology ; Infant, Very Low Birth Weight/blood ; Leukomalacia, Periventricular/epidemiology ; Male ; Platelet Transfusion ; Practice Guidelines as Topic ; Retinopathy of Prematurity/epidemiology ; Retrospective Studies ; Sepsis/epidemiology ; Transfusion Reaction/epidemiology
    Language English
    Publishing date 2019-06-20
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 645021-0
    ISSN 1476-5543 ; 0743-8346
    ISSN (online) 1476-5543
    ISSN 0743-8346
    DOI 10.1038/s41372-019-0408-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top